Cytomegalovirus (CMV) is a major cause of morbidity and mortality following solid organ
transplantation (SOT). Two strategies, prophylactic, and preemptive have emerged for the …

Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid
organ transplantation, and it contributes significantly to mortality and morbidity. CMV …

We systematically reviewed and meta-analyze the efficacy of universal prophylaxis (UP) and
preemptive (PE) strategies (using ganciclovir or valganciclovir) in preventing …

BACKGROUND: Cytomegalovirus (CMV) is a significant infectious agent after liver
transplantation. To prevent CMV, most centres use prophylaxis for high-risk CMV …

Background The role of secondary cytomegalovirus (CMV) prophylaxis, defined as the
continuation of valganciclovir to prevent relapse after the successful treatment of CMV …

BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

Background. Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid
organ transplant recipients. Preemptive treatment with antiviral agents of patients with CMV …

BACKGROUND: Cytomegalovirus (CMV) infections are among the most common infections
following liver transplantation. The main preventive methods for CMV infections are …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

Background Cytomegalovirus (CMV) is the most important viral pathogen in solid organ
transplant (SOT) recipients. The role of secondary CMV prophylaxis in this population …